Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 1,183.9 million
▲ 4% vs 2024
Profit
Healthy€ 18.9 million
▼ 29% vs 2024
Debts
High€ 141.2 million
▲ 44% vs 2024
CYTIVA BELGIUM from Hoegaarden, company number BE0783590249, closed financial year 2025 with a result of € 18.9 million after tax. For that financial year CYTIVA BELGIUM recorded revenue of € 1,183.9 million and equity of € 12.4 million. Compared with financial year 2024, the result moved from € 26.5 million to € 18.9 million. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.
What happened at CYTIVA BELGIUM?
What happened at CYTIVA BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 18.9 million (▼ 29% vs 2024). Source: NBB ↗
- Sylvia Steenwinckel became a director. NBB
- Steven Vanhamel became a director. NBB
- Bernard Goethals became a director. NBB
- New establishment in Hoegaarden. KBO
- Start of the company according to the CBE. KBO
In short
From € 15.1 million profit in 2023 to € 18.9 million profit in 2025.
Paid € 20.7 million in corporate taxes since 2023.
Best year ever: 2024, with € 26.5 million profit.
Paid out € 60 million in dividends to the owners in total.
A new publication or filing at CYTIVA BELGIUM? We notify you, reason included.
Follow CYTIVA BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind CYTIVA BELGIUM are Bernard Goethals, Sylvia Steenwinckel and Steven Vanhamel. The shares are held by Pall Life Sciences Belgium (100%).
Directors
According to the 2025 annual accounts
since 2023
since 2024
since 2023
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Reugelstraat 2
3320 Hoegaarden
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
Details
- Company number
- 0783.590.249
- VAT number
- BE 0783.590.249
- Registered office
- Reugelstraat 2, 3320 Hoegaarden
- Names & denominations
- CYTIVA BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 March 2022
- Peppol
- Active · Active since 23 Jan 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria
Overige bouwinstallatie
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige technische testen en toetsen
Vervaardiging van farmaceutische grondstoffen
Overige bouwinstallatie, n.e.g.
+1